These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32266537)
1. Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively. Zhou X; Li R; Jing R; Zuo B; Zheng Q J Cancer Res Clin Oncol; 2020 Jun; 146(6):1509-1521. PubMed ID: 32266537 [TBL] [Abstract][Full Text] [Related]
2. Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice. Song CQ; Li Y; Mou H; Moore J; Park A; Pomyen Y; Hough S; Kennedy Z; Fischer A; Yin H; Anderson DG; Conte D; Zender L; Wang XW; Thorgeirsson S; Weng Z; Xue W Gastroenterology; 2017 Apr; 152(5):1161-1173.e1. PubMed ID: 27956228 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling. Chang RM; Xu JF; Fang F; Yang H; Yang LY Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma. Sun W; He B; Yang B; Hu W; Cheng S; Xiao H; Yang Z; Wen X; Zhou L; Xie H; Shen X; Wu J; Zheng S Lab Invest; 2018 Jun; 98(6):734-744. PubMed ID: 29467456 [TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway. Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171 [TBL] [Abstract][Full Text] [Related]
6. Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway. Xu Z; Hu J; Cao H; Pilo MG; Cigliano A; Shao Z; Xu M; Ribback S; Dombrowski F; Calvisi DF; Chen X Exp Mol Med; 2018 Jan; 50(1):e417. PubMed ID: 29303510 [TBL] [Abstract][Full Text] [Related]
7. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Xue W; Chen S; Yin H; Tammela T; Papagiannakopoulos T; Joshi NS; Cai W; Yang G; Bronson R; Crowley DG; Zhang F; Anderson DG; Sharp PA; Jacks T Nature; 2014 Oct; 514(7522):380-4. PubMed ID: 25119044 [TBL] [Abstract][Full Text] [Related]
8. Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis. Li JJ; Yin HK; Guan DX; Zhao JS; Feng YX; Deng YZ; Wang X; Li N; Wang XF; Cheng SQ; Bao Y; Xie D Br J Cancer; 2018 May; 118(10):1337-1348. PubMed ID: 29717200 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression. Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level. Wu Q; Yu S; Chen J; Li Y; Gao Y IUBMB Life; 2018 Feb; 70(2):120-128. PubMed ID: 29283497 [TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma. Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495 [TBL] [Abstract][Full Text] [Related]
12. MiR-371 promotes proliferation and metastasis in hepatocellular carcinoma by targeting PTEN. Wang H; Zhao Y; Chen T; Liu G; He N; Hu H BMB Rep; 2019 May; 52(5):312-317. PubMed ID: 30940319 [TBL] [Abstract][Full Text] [Related]
13. Circular RNA circHIAT1 inhibits cell growth in hepatocellular carcinoma by regulating miR-3171/PTEN axis. Wang Z; Zhao Y; Wang Y; Jin C Biomed Pharmacother; 2019 Aug; 116():108932. PubMed ID: 31108351 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression. Chang S; Chen B; Wang X; Wu K; Sun Y BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA THOR promotes cell proliferation and metastasis in hepatocellular carcinoma. Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N Gene; 2018 Dec; 678():129-136. PubMed ID: 30098425 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA. Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733 [TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-based Pten knock-out and Sleeping Beauty Transposon-mediated Nras knock-in induces hepatocellular carcinoma and hepatic lipid accumulation in mice. Gao M; Liu D Cancer Biol Ther; 2017 Jul; 18(7):505-512. PubMed ID: 28513320 [TBL] [Abstract][Full Text] [Related]
18. Genome-scale CRISPR activation screening identifies a role of LRP8 in Sorafenib resistance in Hepatocellular carcinoma. Cai J; Chen J; Wu T; Cheng Z; Tian Y; Pu C; Shi W; Suo X; Wu X; Zhang K Biochem Biophys Res Commun; 2020 Jun; 526(4):1170-1176. PubMed ID: 32312520 [TBL] [Abstract][Full Text] [Related]
19. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
20. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells. Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]